Company Information
CIN
Status
Date of Incorporation
04 April 2001
State / ROC
Hyderabad / ROC Hyderabad
Last Balance Sheet
31 March 2023
Last Annual Meeting
30 September 2023
Paid Up Capital
170,331,000
Authorised Capital
205,000,000
Directors
Prasanth Nandigala
Director/Designated Partner
almost 2 years ago
almost 2 years ago
Mundla Maha Vishnu
Director/Designated Partner
almost 2 years ago
almost 2 years ago
Narayana Reddy Mundla
Director/Designated Partner
over 2 years ago
over 2 years ago
Venkata Reddy Nandigala
Director/Designated Partner
over 2 years ago
over 2 years ago
Hemanth Nandigala
Director/Designated Partner
over 2 years ago
over 2 years ago
Murali Krishna Reddy Tummuru
Director/Designated Partner
about 9 years ago
about 9 years ago
Patents
The present invention relates to a novel, storage stable, synergistic composition of PDGF-BB. The novel composition comprises of PDGF-BB in conjunction with carbohydrates and a cross linking agent. The composition of the present invention is stable for extended periods over significant range of temperatures, without...
The present invention relates to a novel drug delivery device.
A NOVEL CARTRIDGE FOR DELIVERY OF LOW MOLECULAR WEIGHT HEPARIN
The present invention pertains to a novel cartridge for delivery of low molecular weight heparin comprising: a) a housing assembly (400); b) a mechanical device termed as plunger (500) for generating force capable of pushing a drug present in the drug r...
The present invention is for a pharmaceutical composition of lyophilized urate oxidase drug product with a diluent wherein the diluent comprises of propylene glycol and poloxamer 188 in the ratio of 9:1, which aggregate free, and physically stable solution after reconstitution.
The diluent is a combination of GRAS ...
A liposomal formulation for the treatment of cardiovascular diseases, said formulation comprising: lipid moiety; and biologically active recombinant human brain natriuretic peptide (rhBNP).
The present invention provides methods and pharmaceutical compositions for use in topical delivery of genetic material and/or proteins. In addition, the present invention provides methods and compositions for enhancing and/or controlling chronic wounds by applying a wound care device comprising a cationic amphiphile...
The present invention relates to conjugate of Interferon covalently linked to a polymer such polyethylene glycol predominantly at the lysine residue to the protein, wherein preferentially, one polymer strand gets linked to one interferon molecule. The conjugate is attached at the lysine such as at the positions of L...
A process for the production and recovery of the recombinant human BNP obtained as a fusion protein of length of about 98 amino acid comprising the steps of: a) transformation of host cells with an expression vector comprising a gene coding for a fusion protein b) culturing the transformed host cell, so as the expre...
The present invention relates to the field of biopharmaceutical sciences. More specifically, it relates to a stable composition of PEG-interferon conjugates and process for the preparation of the same.
STABLE LYOPHILIZED PEG CONJUGATES
ABSTRACT
The present invention relates to storage stable composition of PEG conjugates. The composition of the present invention is stable for an extended period which is suitable to maintain the robust transit conditions over significant range of temperatures, without any degrada...
The synthesis of highly efficient silver nanoparticles via microbes that are made by chemical mutagenesis technique and that could express higher amounts of enzyme responsible for silver salt reduction with many folds of increased activity. Thus formed silver nanoparticles are relatively more effective and have grea...
A nutritional suspension composition comprising at least one live microorganism, at least one low or zero calorie sweetener, at least one flavor and dispersion medium packaged in a colored Blow-Fill-Seal container has been disclosed herein.
The present invention discloses a tamper evident cap for a customized two beveled needle configurations to provide a single use needle configurations to prevent unauthorized access and use of needle port. The tamper evident cap has four projections that kept pierced inside the protective hub that have four apertur...
Abstract
The present invention relates to the combination of a sterile two bevel needle wherein the needle consists of tamper evident cap that can be used for subcutaneous and/or intramuscular administration and a sterile two chamber vial that has been molded as blow-fill-seal vial. The present invention also provi...
Described herein does a sterile protective cover comprise an intracameral therapeutic agentdelivery device in the form of a pen-injector comprising a cartridge container for dispensing multiple doses of a medicament, coupled to an actuation assembly within a housing. A needle assembly is coupled to the distal end of...
Described herein is a sterile protective cover comprising an intracameral therapeutic agent delivery device in the form of a pen-injector comprising a cartridge container for dispensing multiple doses of a medicament, coupled to an actuation assembly within a housing. A needle assembly is coupled to the distal end o...
The present invention discloses a convergent device in health care facility that can get access of multiple devices such as microscope, endoscope and other diagnostic devices thereof in a single run and might be considered as a Wi Fi router operated using smartphones thus imparting the device a hands free feature th...
The present invention relates to improved pharmaceutical compositions of diclofenac or salts thereof comprising nano size droplets of diclofenac or salts thereof along with other pharmaceutically acceptable excipients. These compositions exhibit excellent photo stability, greater permeability, and improved bioavaila...
The present invention relates to a single use interchangeable primary container that contains drug in the form of solution, suspension irrespective of viscous and non-viscous liquid. The present invention also relates to an interchangeable single use primary drug container comprising (i) a cartridge holder made of...
Disclosed herewith removal of free acrylamide monomer content from a polymer intended to be used in the manufacturing of antimicrobial gel formulations. Removal of free acrylamide monomer content has been achieved by washing the polymer with sulphite solution thus providing a safer alternative to wound healing proce...
The present invention relates to novel processes for the preparation of iron (III) carbohydrate complex. Thus, for example, starch was oxidised using various oxidizing agents such as hydrogen peroxide, sodium hypochlorite, oxone to obtain oxidized sugar derivative. The oxidized product was reacted with ferric hydrox...
The present invention relates to a technique for the preparation of protein G and/or fragments thereof with the capability of binding immunoglobulin G (IgG). Moreover, this invention generally relates to processes for purifying antibodies. More specifically it relates to antibody purification by affinity chromatogra...
The present invention relates to a method to achieve high potent antibodies by modifying the conventional immunization of horses against snake venom by employing one or more adjuvant of nano range alone or in combination, optionally one or more pharmaceutically acceptable excipients and varying the venom concentrati...
The present invention relates to probiotic compositions, and more particularly to a method of preparing a probiotic composition comprising mixed non-pathogenic bacteria strains which may be stored in biologically active form for long periods of time, as well as compositions thereof wherein the Probiotic composition ...
ABSTRACT
SNAP NEEDLE AUTOINJECTOR CARTRIDGE SYSTEM
The present invention relates to a snap needle auto-injector cartridge system, a sterile medical device for the safe, convenient and mechanical administration of the precise parenteral medications comprising of an improved standard glass cartridge (CA) for a medic...
Registered Trademarks
[Class : 5] Pharmaceutical & Medicinal Preparations
[Class : 5] Pharmaceutical Preparations; Dietetic Substances Adapted For Medical Use.
[Class : 5] Pharmaceutical Preparations; Dietetic Substances Adapted For Medical Use.
View +9 more Brands for Virchow Biotech Private Limited.
Charges
03 April 2019
Citi Bank N.a.
50 Crore
11 April 2017
Citi Bank N.a.
100 Crore
11 November 2016
Citi Bank N.a.
21 Crore
20 October 2016
Biotechnology Industry Research Assistance Council
5 Crore
20 April 2009
Biotechnology Industry Research Assistance Council
7 Crore
16 May 2011
Canara Bank
4 Crore
30 October 2004
Technology Dev. Board
2 Crore
15 March 2002
Canara Bank
1 Crore
16 November 2006
Uti Bank Limited
4 Crore
31 October 2022
Hdfc Bank Limited
0
08 September 2021
Hdfc Bank Limited
0
20 October 2016
Others
0
11 November 2016
Citi Bank N.a.
0
11 April 2017
Citi Bank N.a.
0
15 March 2002
Canara Bank
0
16 November 2006
Uti Bank Limited
0
16 May 2011
Canara Bank
0
20 April 2009
Others
0
03 April 2019
Citi Bank N.a.
0
30 October 2004
Technology Dev. Board
0
31 October 2022
Hdfc Bank Limited
0
08 September 2021
Hdfc Bank Limited
0
20 October 2016
Others
0
11 November 2016
Citi Bank N.a.
0
11 April 2017
Citi Bank N.a.
0
15 March 2002
Canara Bank
0
16 November 2006
Uti Bank Limited
0
16 May 2011
Canara Bank
0
20 April 2009
Others
0
03 April 2019
Citi Bank N.a.
0
30 October 2004
Technology Dev. Board
0
31 October 2022
Hdfc Bank Limited
0
08 September 2021
Hdfc Bank Limited
0
20 October 2016
Others
0
11 November 2016
Citi Bank N.a.
0
11 April 2017
Citi Bank N.a.
0
15 March 2002
Canara Bank
0
16 November 2006
Uti Bank Limited
0
16 May 2011
Canara Bank
0
20 April 2009
Others
0
03 April 2019
Citi Bank N.a.
0
30 October 2004
Technology Dev. Board
0
Documents
Form MGT-14-17102020_signed
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-17102020
Optional Attachment-(1)-17102020
Form DPT-3-09032020-signed
Form MGT-7-04112019_signed
Optional Attachment-(1)-02112019
List of share holders, debenture holders;-02112019
Copy of MGT-8-02112019
Form AOC-4(XBRL)-28102019_signed
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-26102019
Optional Attachment-(1)-26102019
XBRL document in respect Consolidated financial statement-26102019
Form ADT-1-15102019_signed
Copy of written consent given by auditor-14102019
Copy of the intimation sent by company-14102019
Copy of resolution passed by the company-14102019
Form DPT-3-27062019
Auditor?s certificate-27062019
Optional Attachment-(1)-27062019
Optional Attachment-(1)-16052019
Instrument(s) of creation or modification of charge;-16052019
Form CHG-1-16052019_signed
CERTIFICATE OF REGISTRATION FOR MODIFICATION OF CHARGE-20190516
Optional Attachment-(1)-14052019
Form CHG-1-14052019_signed
Instrument(s) of creation or modification of charge;-14052019
CERTIFICATE OF REGISTRATION FOR MODIFICATION OF CHARGE-20190514
CERTIFICATE OF REGISTRATION OF CHARGE-20190514
Form CHG-1-10012019_signed
CERTIFICATE OF REGISTRATION FOR MODIFICATION OF CHARGE-20190110
